Condition

Thoracic Paravertebral Block

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 2 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials2
Recruiting1
Common interventions18
Lead sponsors shown2
Advertisement

Common interventions

AdrenalineDRUG1Costotransverse foramen blockOTHER1Dexamethasone contained in the solution for thoracic paravertebral blockDRUG1Dexamethasone, 8 mg intravenouslyDRUG1DexmedetomidinDRUG1ketamineDRUG1LevobupivacaineDRUG1LidocainDRUG1Metoclopramide 10mgDRUG1Nerve stimulator for peripheral nerve blocksDEVICE1Ondasetron 4mgDRUG1Opioid based AnesthesiaPROCEDURE1Opioid free anesthesia based on thoracic paravertebral blockPROCEDURE1Opioid free anesthesia, Opioid free anesthesia based on intravenous dexmedetomidine, ketamine and lidocainedexmedetomidine, ketamine and lidocainePROCEDURE1SufentanilDRUG1ThiethylperazineDRUG1Thoracic paravertebral plane blockOTHER1Ultrasound guided thoracic paravertebral blockDEVICE1

Trial status mix

NOT_YET_RECRUITING1
RECRUITING1

Phase mix

NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.